News

December 27, 2013
Polycomb Potentiates Meis2 Activation in Midbrain by Mediating Interaction of the Promoter with a Tissue-Specific Enhancer PRESS RELEASE
December 26, 2013
Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery PRESS RELEASE
November 14, 2013
Fatty acid produced by gut bacteria boosts the immune system PRESS RELEASE
October 25, 2013
Hope of new treatment for severe asthma patients PRESS RELEASE
October 1, 2013
SAM Domain Polymerization Links Subnuclear Clustering of PRC1 PRESS RELEASE
September 17, 2013
Mitsubishi Chemical Medience Starts Up Evaluating the Usefulness of Glycomics Analysis Services for Glycosylated Biologics and Biosimilars (Dr. Ueda, Senior Research Scientist, Laboratory for Genome Sequencing Analysis) PRESS RELEASE
August 24, 2013
AP-1B-Mediated Protein Sorting Regulates Polarity and Proliferation of Intestinal Epithelial Cells in Mice PRESS RELEASE
July 23, 2013
Statistical significance of combinatorial regulations PRESS RELEASE
July 12, 2013
A coral symbiont genome decoded for first time PRESS RELEASE
July 12, 2013
Repression of Bach2 contributes to predisposition of IgG1 memory B cells PRESS RELEASE
July 11, 2013
Pioneering Study Describes Rationally Designed Drug Candidate Derived From the Human Microbiota PRESS RELEASE
June 13, 2013
Gene Variants May Predict Who Will Benefit From Breast Cancer Prevention Drugs PRESS RELEASE
June 13, 2013
Genetic Variations May Help Identify Best Candidates for Preventive Breast Cancer Drugs PRESS RELEASE
June 11, 2013
Bach2 maintains T cells in a naive state by suppressing effector memory-related genes PRESS RELEASE
June 8, 2013
Pretreatment of Donor Islets With the Na+/Ca2+ Exchanger Inhibitor Improves the Efficiency of Islet Transplantation PRESS RELEASE
April 18, 2013
Compound that prevents acute blood cancer relapse identified in Japan PRESS RELEASE
January 21, 2013
Mature T cells can switch function to better tackle infection PRESS RELEASE
January 4, 2013
Japanese team creates cancer-specific killer T cells from induced pluripotent stem cells (iPSC) PRESS RELEASE